Cholesterol in the year 2000

被引:76
作者
Vance, DE
Van den Bosch, H
机构
[1] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2S2, Canada
[2] Univ Alberta, CIHR Grp Mol & Cell Biol Lipids, Edmonton, AB T6G 2S2, Canada
[3] Univ Utrecht, Dept Biochem Lipids, Ctr Biomembranes & Lipid Enzymol, NL-3508 TB Utrecht, Netherlands
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS | 2000年 / 1529卷 / 1-3期
关键词
cholesterol; Konrad Bloch; sterol regulatory element binding protein; cholesterol biosynthesis; atherosclerosis; evolution;
D O I
10.1016/S1388-1981(00)00133-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cholesterol research was one of the key areas of scientific investigation in the 20th century. Little was known about the structure of cholesterol until the pioneering research of A. Windaus and H. Wieland in the first part of the century. The structure of cholesterol was completely elucidated in 1932. With the development of isotopic tracers in the 1930s studies on cholesterol biosynthesis were initiated. In 1942 K. Bloch and D. Rittenberg showed that deuterium-labeled acetate was incorporated into the ring structure and side chain of cholesterol. Another important discovery from Bloch's laboratory was that squalene was a precursor of cholesterol. In 1956, the main elements of the biosynthetic pathway became known when isopentenyl pyrophosphate was discovered as a precursor. In 1966, J. Cornforth and G. Popjak predicted that there were 16 234 possible stereochemical pathways by which mevalonate could be converted into squalene. They subsequently showed which of these pathways was correct. In the 1970s and 1980s K. Bloch was able to provide intriguing evidence for an evolutionary advantage of cholesterol over lanosterol or some of the intermediates in the conversion of lanosterol to cholesterol. The last quarter of the 20th century was when M. Brown and J. Goldstein showed that the low density lipoprotein receptor was a key regulator of cholesterol homeostasis. They have also demonstrated that cholesterol balance in the cell is transcriptionally regulated via the sterol regulatory element binding protein. In the later part of the 20th century drugs were developed that effectively lower plasma cholesterol and lessen the risk of atherosclerosis and cardiovascular disease. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 19 条
[1]  
Anitschkow N, 1913, ZENTRALBL ALLG PATHO, V24, P1
[2]  
BENTLEY R, 1970, MOL BIOL MOL ASYMMET, V2, P267
[3]   BIOLOGICAL SYNTHESIS OF CHOLESTEROL [J].
BLOCH, K .
SCIENCE, 1965, 150 (3692) :19-&
[4]   THE STRUCTURE OF CHOLESTEROL AND OF THE BILE-ACIDS [J].
BLOCH, K .
TRENDS IN BIOCHEMICAL SCIENCES, 1982, 7 (09) :334-336
[5]  
BLOCH K, 1987, ANNU REV BIOCHEM, V56, P1
[6]  
BLOCH K, 1954, HARVEY LECT, V48, P68
[7]   STEROL STRUCTURE AND MEMBRANE-FUNCTION [J].
BLOCH, KE .
CRC CRITICAL REVIEWS IN BIOCHEMISTRY, 1983, 14 (01) :47-92
[8]   SPECULATIONS ON THE EVOLUTION OF STEROL STRUCTURE AND FUNCTION [J].
BLOCH, KE .
CRC CRITICAL REVIEWS IN BIOCHEMISTRY, 1979, 7 (01) :1-5
[9]   The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor [J].
Brown, MS ;
Goldstein, JL .
CELL, 1997, 89 (03) :331-340
[10]   Regulated intramembrane proteolysis: A control mechanism conserved from bacteria to humans [J].
Brown, MS ;
Ye, J ;
Rawson, RB ;
Goldstein, JL .
CELL, 2000, 100 (04) :391-398